Malignant Hepatobiliary Neoplasm — Trials

Malignant Hepatobiliary Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,029 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,160
Recruiting: 666
Ph III recruiting: 61
Growth YoY: +9.3%
Industry share: 22%
Top sponsor: Sun Yat-sen University
Termination share: 32.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (561)

clinicaltrialsPublishedShowing 451–500 of 1,541 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07646717	Efficacy and Safety of HAIC Combined With Lenvatinib and PD-1 Inhibitors for Advanced Intrahepatic Cholangiocarcinoma(LPHAIC for ICC)	active not recruiting	Phase 2	30	Tianjin Medical University Cancer Institute and HospitalOTHER	1	Jun 15, 2026	clinicaltrials
NCT05075993	Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors	active not recruiting	Phase 1	352	M.D. Anderson Cancer CenterOTHER